ConjuGon raises $1.9M for antibacterial drugs

ConjuGon Inc. has raised $1.9 million in equity to develop drugs that combat bacterial infections, according to a Securities and Exchange Commission filing. The fundraise comes from three investors and is part of an offering that the company hopes will bring in $4.75 million. Late last month, the Food and Drug Administration cleared ConjuGon’s Investigational […]